Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bharat Biotech has delivered over nine billion doses of vaccines globally as of May 2025. Its portfolio includes more than 19 vaccines and four biotherapeutics with registrations in over 125 countries. Recent clinical milestones include successful Phase III trials for its oral cholera vaccine Hillchol demonstrating efficacy against both Ogawa and Inaba serotypes. The COVID-19 vaccine Covaxin was widely used during the pandemic with emergency use approvals for adults and children.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BharathRise.